Neurodon Announces Initiation of Investigational New Drug (IND)-Enabling Studies for NDC-0009, a Novel Small Molecule…
Colleen MaugerMay 20, 2021
CROWN POINT — Neurodon Corp. announced today that the company has entered into an agreement…
Colleen MaugerMarch 31, 2021
A $2 million grant from the National Institute on Aging at the National Institutes of…
Colleen MaugerAugust 12, 2020
Neurodon Corporation (https://neurodon.net), a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics…
Colleen MaugerFebruary 17, 2020
Neurodon Welcomes Brunde Broady to its Board of Directors Neurodon Corporation announced today the appointment…
Colleen MaugerOctober 3, 2019
WEST LAFAYETTE, Ind. – A Purdue University graduate and a Purdue Research Park of Northwest…
Colleen MaugerMay 9, 2019
Neurodon Receives Funding from Elevate Ventures Through the 21st Century Research & Technology Fund …
Colleen MaugerJanuary 4, 2019
Neurodon Awarded Phase I NIH STTR Grant for Alzheimer’s Disease Drug Discovery Neurodon Corporation, an…
Colleen MaugerSeptember 24, 2018
PRLog -- Neurodon LLC, a leader in disease-modifying treatments for neurodegenerative diseases like Parkinson's, Alzheimer's, and…
Colleen MaugerFebruary 5, 2018